Heavy legs, chronic venous insufficiency and hormonal replacement therapy;Jambes lourdes, insuffisance veineuse des membres inférieurs et hormonothérapie substitutive

Praxis

Volumn 89, Issue 25-26, 2000, Pages 1098-1104

  Haesler, E ^a   Hayoz, D ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Heavy legs; Hormones; Menopause; Thromboembolism; Venous insuffiency

Indexed keywords

GESTAGEN; HORMONE; ORAL CONTRACEPTIVE AGENT;

CHRONIC VEIN INSUFFICIENCY; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; PATHOGENESIS; PATHOPHYSIOLOGY; PROGNOSIS; RECEPTOR DENSITY; REVIEW; THROMBOEMBOLISM;

ADULT; AGE FACTORS; AGED; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; PULMONARY EMBOLISM; RISK FACTORS; VENOUS INSUFFICIENCY; VENOUS THROMBOSIS;

EID: 0034729672     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. P. M. Vanhoutte, S. Corcaud and C. De Montrion. Venous disease: From pathophysiology to quality of life. Angiology 1997;48:559-567. (Pubitemid 27342626)
2. C. V. Ruckley. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology 1997;48:67-69.
3. G. De Backer. Epidemiology of chronic venous insufficiency. Angiology 1997;48:569-576. (Pubitemid 27342627)
4. A. Sobaszek, P. Frimat, A. Tiberguent, A. Domont, H. Chevalier and P. Catilina. Venous insufficiency of the lower limbs and working conditions. Phlebology 1998;13:133-141. (Pubitemid 29253717)
5. H. Olsen and T. Länne. Reduced venous compliance in lower limbs of aging humans and its importance for capacitance function. Am. J. Physiol. 1998;275:H878-H886.
6. F. A. Allaert, M. Levardon and F. Vin. Influence de l'obé sité sur la maladie veineuse. Etude des facteurs concomitants. Phlébologie 1991;44:271-280.
7. F. Vin, F. A. Allaert and M. Levardon. Pathologie veineuse sous oestroprogestatifs. Phlébologie 1989;42:473-480.
8. N. R. Poulter, C. L. Chang, T. M. M. Farley, O. Meirik and M. G. Marmot. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995;346:1575-1582. (Pubitemid 26001838)
9. M. Aiach. Interaction entre les oestrogènes et les facteurs génétiques de risque de thrombose. Thérapie 1999;54:357-361. (Pubitemid 29429842)
10. D. Grady, S. B. Hulley and C. Furberg. Venous thromboembolic events associated with hormone replacement therapy. J.A.M.A. 1997;278:477. (Pubitemid 27343997)
11. E. Daly, M. P. Vessey, M. M. Hawkins, C. J. L, P. Gough and S. Marsh. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977-980. (Pubitemid 26340751)
12. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs and E. Vittinghoff. Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women. J.A.M.A. 1998;280:605-613. (Pubitemid 28502636)
13. H. P. Schneider. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe. Int. J. Fertility Womens Med. 1997;42 Suppl 2:365-375.
14. F. Paccaud and B. Santos-Eggimann. Vieillissement de la population, besoins de santé et réponse sanitaire. Med. Hyg. 1999;57:2042-2044.
15. E. Barrett-Connor and D. Grady. Hormone replacement therapy, heart disease, and other considerations. Annual Revue of Public Health 1998;19:55-72. (Pubitemid 28279924)
16. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J.A.M.A. 1995;273:199-208.
17. M. E. Espeland, S. M. Marcovina, V. Miller, P. D. Wood, C. Wasilauskas, R. Sherwin, H. Schrott and T. L. Bush. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. Circulation 1998;97:979-986. (Pubitemid 28125470)
18. R. E. De Meersmann, A. S. Zion, E. G. V. Giardina, J. P. Weir, J. S. Liebermann and J. A. Downey. Estrogen replacement, vascular distensibility, and blood pressures in postmenopausal women. Am. J. Physiol. 1998;274:H1539-H1544.
19. R. S. Rosenson, C. C. Tangney and L. J. Mosca. Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 1998;18:1902-1905.
20. P. Y. Scarabin, M. Alhenc-Gelas, G. Plu-Bureau, P. Taisne, R. Agher and M. Aiach. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 1997;17:3071-3078. (Pubitemid 28016061)
21. M. Cushman, E. N. Meilahn, B. M. Psaty, L. H. Kuller, A. S. Dobs and R. P. Tracy. Hormone replacement therapy, inflammation, and hemostasis in elderly women. Arterioscler. Thromb. Vasc. Biol. 1999;19:893-899. (Pubitemid 29177335)
22. D. Dai-Do, E. Espinosa, G. Liu, T. J. Rabelink, F. Julmy, Z. Yang, R. Mahler and T. F. Lüscher. 17--estradiol inhibits proliferation and migration of human vascular smooth cells: similar effects in cells from postmenopausal females and in males. Cardiovasc. Res. 1996;32:980-985. (Pubitemid 26342664)
23. M. Gerhard, B. W. Walsh, A. Tawakol, E. A. Haley, S. J. Creager, E. W. Seely, P. Ganz and M. A. Craeger. Estradiol therapy combined with progesterone and endothelium- Dependent vasodilation in postmenopausal women. Circulation 1998;98:1158-1163. (Pubitemid 28436164)
24. K. E. Sorensen, I. Dorup, A. P. Hermann and L. Mosekilde. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998;97:1234-1238. (Pubitemid 28169174)
25. M. Cushman, C. Legault, E. Barrett-Connor, M. L. Stefanick, C. Kessler, H. L. Judd, P. A. Sakkinen and R. P. Tracy. Effect of postmenopausal hormones on inflammation-sensitive proteins. The postmenopausal estrogen/progestin interventions (PEPI) study. Circulation 1999;100:717-722. (Pubitemid 29383641)
26. P. M. Ridker, C. H. Hennekens, N. Rifai, J. E. Buring and J. E. Manson. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999;100:713-716. (Pubitemid 29383640)
27. K. Rödström, C. Bengtsson, L. Lissner and C. Björkelund. Pre- Existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden. B.M.J. 1999;319:890-893.
28. R. C. J. Ribeiro, P. J. Kushner and J. D. Baxter. The nuclear hormone receptor gene superfamily. Annu. Rev. Med. 1995;46:443-453.
29. M. Wehling. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 1997;59:365-393. (Pubitemid 27142447)
30. A. Bergqvist, D. Bergqvist and M. Ferno. Estrogen and progesterone receptors in vessel walls. Biochemical and immunochemical assays. Acta Obstet. Gynecol. Scand. 1993;72:10-16. (Pubitemid 23074896)
31. R. H. Karas, B. L. Patterson and M. E. Mendelsohn. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994;89:1943-1950.
32. M. Perrot-Applanat, K. Cohen-Solal, E. Milgrom and M. Finet. Progesterone receptor expression in human saphenous veins. Circulation 1995;92:2975-2983.
33. S. Mosselman, J. Polman and R. Dijkema. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996;392:49-53. (Pubitemid 26268330)
34. Y. K. Hodges, J. K. Richer, K. B. Horwitz and L. D. Horwitz. Variant estrogen and progesterone receptor messages in human vascular smooth muscle. Circulation 1999;99:2688-2693.
35. R. H. Karas, W. E. Baur, M. Van Eickles and M. E. Mendelsohn. Human vascular smooth muscle cells express an estrogen receptor isoform. FEBS Lett. 1995;377:103-108. (Pubitemid 26018519)
36. K. Sudhir, M. D. Elser, J. L. Jennings and P. A. Komesaroff. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 1997;30:1538-1543. (Pubitemid 27528101)
37. A. Tollan, K. Kvenild, H. Strand, P. Oian and J. M. Maltau. Increased capillary permeability for plasma proteins in oral contraceptive users. Contraception 1992;45:473-481.
38. S. M. Gapstur, M. Morrow and T. A. Sellers. Hormone replacement therapy and risk of breast cancer with a favorable histology. Results of the Iowa Women's Health Study. J.A.M.A. 1999;281:2091-2097.